BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Selnoflast readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Selnoflast\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07448038-1127@assetmemo.bio
DTSTAMP:20261121T005836Z
DTSTART;VALUE=DATE:20280131
DTEND;VALUE=DATE:20280201
SUMMARY:Selnoflast: Phase 2 readout est. (NCT07448038)
DESCRIPTION:Selnoflast\, phase 2\, Atherosclerotic Cardiovascular Disease.\
 nStudy: A Study to Evaluate the Efficacy\, Safety\, Pharmacodynamics (PD)\
 , and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammatio
 n in Participants With Atherosclerosis at Risk for Major Adverse Cardiac E
 vents\nEstimated primary completion: 31 January 2028. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/selnoflast#upcoming-events\nRegistry reco
 rd: https://clinicaltrials.gov/study/NCT07448038
URL:https://assetmemo.bio/drug/selnoflast#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
